$First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine Ophthalmic Solution 0.75% (PS) for the Treatment of Decreased Visual Acuity Under Low Light Conditions Following Keratorefractive Surgery$

PremiumPress Releases

First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine Ophthalmic Solution 0.75% (PS) for the Treatment of Decreased Visual Acuity Under Low Light Conditions Following Keratorefractive Surgery

7d ago

OCUP

PremiumPress Releases

Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris

17d ago

OCUP

PremiumThe Fly

Ocuphire Pharma announces U.S. commercial launch of RYZUMVI

17d ago

OCUP

VTRS

PremiumCompany Announcements

Ocuphire Pharma Engages Investors with Presentation Update

22d ago

OCUP

PremiumThe Fly

Ocuphire Pharma price target lowered to $20 from $24 at Alliance Global

29d ago

OCUP

More OCUP News >

OCUP News on the Web

2024-03-27

Ocuphire Pharma Engages Investors with Presentation Update

TipRanks News

Neutral

2024-03-15

OCUP Stock Earnings: Ocuphire Pharma Misses EPS, Misses Revenue for Q4 2023

InvestorPlace

Neutral

2024-03-13

Earnings Update: Ocuphire Pharma, Inc. Just Reported And Analysts Are Trimming Their Forecasts

Yahoo Finance

Neutral

2024-03-10

Ocuphire Pharma Full Year 2023 Earnings: Misses Expectations

Yahoo Finance

Neutral

2024-03-08

Ocuphire Pharma Announces Financial Results for Fourth Quarter and Full Year 2023 and Provides Corporate Update

Yahoo Finance

Neutral

2024-03-04

Ocuphire (OCUP) to Report Q4 Earnings: What's in the Cards?

Zacks

Neutral

2024-02-26

7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff

InvestorPlace

Neutral

2024-02-23

Ocuphire Pharma to Present in the BIO CEO & Investor Conference

Yahoo Finance

Neutral

News Score - Last 7 Days

Neutral

OCUP

Sector Average

Media Buzz

This Week1 articles

Weekly Average1.5 articles

News Sentiment

This Week50%

Sector Average64%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is OCUP’s Media Buzz Sentiment?

1 articles about OCUP were published this week. In an average week, 1.5 articles are published.

What is OCUP’s weekly average amount of articles?

In an average week, 1.5 articles about OCUP are published.

What is OCUP’s News Sentiment?

50% of articles about OCUP were positive this week, compared to its sector average of 64%.

Healthcare Stocks that are Trending in the News

STROSutro Biopharma

ERASErasca

THRDThird Harmonic Bio, Inc.

MASIMasimo

STOKStoke Therapeutics

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing